Literature DB >> 7774709

Phospholipid membrane permeability of peptide nucleic acid.

P Wittung1, J Kajanus, K Edwards, P Nielsen, B Nordén, B G Malmström.   

Abstract

Phospholipid vesicles (liposomes) as membrane models have been used to study the penetration properties of peptide nucleic acid (PNA), a new DNA analog in which the nucleobases are attached to a pseudo-peptide backbone. The liposomes were characterised by carboxyfluorescein efflux, light-scattering and cryogenic transmission electron microscopy. The liposome structure was found not to be affected by the incorporation of PNA or an oligonucleotide. Two 10-mer fluorescein-labelled PNAs were found to have low efflux rates (half-times of 5.5 and 11 days), comparable to a 10-mer oligonucleotide (half-time of 7 days). We conclude that passive diffusion of unmodified PNA is not an effective way of transport into biological cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774709     DOI: 10.1016/0014-5793(95)00409-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

2.  Efficiency of cellular delivery of antisense peptide nucleic acid by electroporation depends on charge and electroporation geometry.

Authors:  Mette Joergensen; Birgit Agerholm-Larsen; Peter E Nielsen; Julie Gehl
Journal:  Oligonucleotides       Date:  2011-01-14

3.  Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Authors:  S Sei; Q E Yang; D O'Neill; K Yoshimura; K Nagashima; H Mitsuya
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA.

Authors:  L Good; P E Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 5.  Treatment of mitochondrial disease.

Authors:  R W Taylor; P F Chinnery; K M Clark; R N Lightowlers; D M Turnbull
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

6.  Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element.

Authors:  Sabyasachi Ganguly; Binay Chaubey; Snehlata Tripathi; Alok Upadhyay; Prasad V S V Neti; Roger W Howell; Virendra Nath Pandey
Journal:  Oligonucleotides       Date:  2008-09

7.  Inhibition of multidrug resistance by SV40 pseudovirion delivery of an antigene peptide nucleic acid (PNA) in cultured cells.

Authors:  Benjamin Macadangdang; Ning Zhang; Paul E Lund; Andrew H Marple; Mitsunori Okabe; Michael M Gottesman; Daniel H Appella; Chava Kimchi-Sarfaty
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

8.  Sequence-selective recognition of double-stranded RNA and enhanced cellular uptake of cationic nucleobase and backbone-modified peptide nucleic acids.

Authors:  Dziyana Hnedzko; Dennis W McGee; Yannis A Karamitas; Eriks Rozners
Journal:  RNA       Date:  2016-10-14       Impact factor: 4.942

9.  In situ synthesis of peptide nucleic acids in porous silicon for drug delivery and biosensing.

Authors:  Kelsey R Beavers; Jeremy W Mares; Caleb M Swartz; Yiliang Zhao; Sharon M Weiss; Craig L Duvall
Journal:  Bioconjug Chem       Date:  2014-06-24       Impact factor: 4.774

10.  Impact of Chirality and Position of Lysine Conjugation in Triplex-Forming Peptide Nucleic Acids.

Authors:  Christopher A Ryan; Eriks Rozners
Journal:  ACS Omega       Date:  2020-10-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.